Intense Pulsed Light (IPL) and Low-Level Light Therapy (LLLT) | AHMC

INTENSE PULSED LIGHT AND LOW-LEVEL LIGHT THERAPY

Intense Pulsed Light and Low-Level Light Therapy is a noninvasive, clinic-based treatment designed to improve dry eye disease caused by meibomian gland dysfunction. This service uses controlled light energy to reduce eyelid inflammation and restore healthy oil flow in the tear film. As a result, many patients experience better comfort, clearer vision, and more stable tears.

WHAT THIS SERVICE DOES

This combined therapy targets the root causes of evaporative dry eye. Intense Pulsed Light delivers precise pulses of filtered light to the skin around the eyelids. Consequently, it reduces abnormal blood vessels and inflammatory mediators. Low-Level Light Therapy then applies gentle, therapeutic light to warm and stimulate the meibomian glands. Therefore, thickened oils soften and flow more easily.

WHO MAY BENEFIT

Your eye doctor may recommend this treatment if you have ongoing dry eye symptoms despite using artificial tears or medications. It is often helpful for patients with the following findings:

1. Meibomian gland dysfunction
2. Evaporative dry eye disease
3. Ocular rosacea
4. Chronic eyelid inflammation
5. Recurrent styes or chalazia

HOW THE PROCEDURE IS PERFORMED

First, the skin around the eyes is cleaned and prepared. Protective shields are placed to cover the eyes. Then, controlled light pulses are delivered to the treatment area using a medical device. After that, Low-Level Light Therapy is applied using a dedicated light mask or panel. Each session usually lasts 15 to 30 minutes. Most treatment plans include a series of sessions spaced over several weeks.

WHAT YOU MAY EXPECT

Most patients report only mild warmth or a snapping sensation during Intense Pulsed Light delivery. Meanwhile, Low-Level Light Therapy feels gentle and relaxing. There is little to no downtime, so patients usually return to normal activities on the same day. However, your doctor may advise sun protection and specific eyelid care after each visit.

SAFETY AND CLINICAL VALUE

Published clinical studies support light-based therapy for selected dry eye patients, especially those with meibomian gland dysfunction. When trained professionals perform the procedure using approved devices, the safety profile is favorable. Still, proper screening remains essential. Your ophthalmologist will review your eye status, skin type, medications, and medical history before treatment.

WHY EARLY TREATMENT HELPS

Early control of eyelid inflammation improves tear stability and protects the ocular surface. Moreover, better gland function reduces symptom flare-ups and dependence on frequent eye drops. With timely treatment and follow-up, many patients achieve longer-lasting dry eye relief and improved daily comfort.